GLP1R and type 2 diabetes mellitus: Specifically, beyond the metabolic effect on diabetic and/or obese subjects, [99] a meta-analysis carried out with eight different trials in T2DM patients, also reported the effect of different GLP-1R agonists on cardiovascular and kidney outcomes.